Literature DB >> 8131063

Decreased activities of thiamine diphosphatase in frontal and temporal cortex in Alzheimer's disease.

V L Rao1, J S Richardson, R F Butterworth.   

Abstract

Thiamine diphosphatase (TDPase) activity was measured using a colorimetric assay in frontal and temporal cortex obtained at autopsy from eight patients with neuropathologically confirmed Alzheimer's disease (AD) and from an equal number of control patients matched for age and autopsy delay interval, free from neurological or psychiatric disorders. TDPase activities were significantly reduced in frontal cortex (by 28%, P < 0.05) and temporal cortex (by 62%, P < 0.01) of AD patients. These findings add to a growing body of evidence of altered thiamine neurochemistry in AD. Given the previous reports of an association of TDPase with cholinergic nerve terminals, loss of TDPase activities could reflect loss of cholinergic neurons in frontal and temporal cortex in AD.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8131063     DOI: 10.1016/0006-8993(93)91554-6

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  7 in total

1.  Plasma thiamine deficiency associated with Alzheimer's disease but not Parkinson's disease.

Authors:  M Gold; R A Hauser; M F Chen
Journal:  Metab Brain Dis       Date:  1998-03       Impact factor: 3.584

Review 2.  Thiamine in excitable tissues: reflections on a non-cofactor role.

Authors:  L Bettendorff
Journal:  Metab Brain Dis       Date:  1994-09       Impact factor: 3.584

Review 3.  Pathophysiology of alcoholic brain damage: synergistic effects of ethanol, thiamine deficiency and alcoholic liver disease.

Authors:  R F Butterworth
Journal:  Metab Brain Dis       Date:  1995-03       Impact factor: 3.584

4.  Thiamine therapy in Alzheimer's disease.

Authors:  Y Mimori; H Katsuoka; S Nakamura
Journal:  Metab Brain Dis       Date:  1996-03       Impact factor: 3.584

Review 5.  Alterations of thiamine phosphorylation and of thiamine-dependent enzymes in Alzheimer's disease.

Authors:  M Héroux; V L Raghavendra Rao; J Lavoie; J S Richardson; R F Butterworth
Journal:  Metab Brain Dis       Date:  1996-03       Impact factor: 3.584

6.  Benfotiamine treatment activates the Nrf2/ARE pathway and is neuroprotective in a transgenic mouse model of tauopathy.

Authors:  Victor Tapias; Shari Jainuddin; Manuj Ahuja; Cliona Stack; Ceyhan Elipenahli; Julie Vignisse; Meri Gerges; Natalia Starkova; Hui Xu; Anatoly A Starkov; Lucien Bettendorff; Dmitry M Hushpulian; Natalya A Smirnova; Irina G Gazaryan; Navneet A Kaidery; Sushama Wakade; Noel Y Calingasan; Bobby Thomas; Gary E Gibson; Magali Dumont; M Flint Beal
Journal:  Hum Mol Genet       Date:  2018-08-15       Impact factor: 6.150

7.  Enhanced Activities of Blood Thiamine Diphosphatase and Monophosphatase in Alzheimer's Disease.

Authors:  Xiaoli Pan; Shaoming Sang; Guoqiang Fei; Lirong Jin; Huimin Liu; Zhiliang Wang; Hui Wang; Chunjiu Zhong
Journal:  PLoS One       Date:  2017-01-06       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.